StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)

Close on Nov 18, 2026Market cap $59.59MP/E –Yield –

Lensar price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lensar's price to sales ratio was 0.9× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.6× to 3.1×, with a median of 1.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−1.4
2025Dec 31, 20252.3×+0.2
2024Dec 31, 20242.1×+1.1
2023Dec 29, 20231.0×+0.1
2022Dec 30, 20220.9×−1.2
2021Dec 31, 20212.1×−0.8
2020Dec 31, 20202.9×–

More Lensar figures

See a number that looks wrong?